跳至主要内容
临床试验/NCT04689802
NCT04689802招募中不适用

To Identify Potential New Urine Marker Panel for Cancer Screening

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2021年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,500
试验地点
1
主要终点
The sensitivity and specificity of cancer detection by urine polyamines

研究概览

简要总结

Polyamines are naturally produced metabolites in our cells. There were some reports suggested the urinary levels of polyamines were altered in patients with different cancers. This study is to explore the use of urinary polyamine for the diagnosis of common cancers.

详细描述

Urine tests is a simple, non-invasive approach for cancer detection. One example of such cancer biomarkers are natural polyamines. Recently, there are also other reports on the use of polyamines in diagnosis of other cancers. In this larger scale study, with inclusion of subjects with different cancer types, to further assess the correlation urine polyamines and other urine metabolite markers for the diagnosis of different cancer types and investigate their role as a potential non-invasive marker for cancer detection and monitoring.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with age > 18 years old.
  • For cancer patients, a histological diagnosis of cancer is available.
  • For normal control, there is no diagnosis of cancer in the medical record.

排除标准

  • Patient with recent urinary tract infection within 6 weeks prior to urine collection.
  • Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to urine collection.
  • Patient refused or unable to provide consent for the study

结局指标

主要结局

The sensitivity and specificity of cancer detection by urine polyamines

时间窗: 1 month after surgery

Urine samples will be prepared and analyzed by ultra-high-performance liquid chromatography coupled with triple quadrupole mass spectrometer (UPLC-MS/MS). Receiver operating characteristics (ROC) curve for overall and individual cancer diagnosis will be performed.pathological result will be assessed.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

NG Chi Fai

Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验

To Identify Potential New Urine Marker Panel for... | 临床试验